Zoetis PE Ratio 2011-2018 | ZTS

Current and historical PE ratio for Zoetis (ZTS) from 2011 to 2018. The price to earnings or PE ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. The current PE ratio for Zoetis (ZTS) as of March 31, 2018 is 32.55.
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.000B $5.307B
Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, complemented by diagnostic products and genetic tests and supported by a range of services.
Stock Name Country Market Cap PE Ratio
Shire (SHPG) Ireland $52.052B 11.13
Grifols (GRFS) Spain $14.565B 18.88
Jazz Pharmaceuticals (JAZZ) Ireland $10.640B 17.90
Neurocrine Biosciences (NBIX) United States $9.298B 0.00
Nektar Therapeutics (NKTR) United States $8.352B 0.00
Sage Therapeutics (SAGE) United States $7.841B 0.00
Catalent (CTLT) United States $5.866B 27.32
Ionis Pharmaceuticals (IONS) United States $5.837B 0.00
United Therapeutics (UTHR) United States $5.444B 9.88
FibroGen (FGEN) United States $5.433B 0.00
Loxo Oncology (LOXO) United States $5.260B 0.00
Taro Pharmaceutical Industries (TARO) Israel $4.453B 18.25
Madrigal Pharmaceuticals (MDGL) United States $4.091B 0.00
Ironwood Pharmaceuticals (IRWD) United States $3.042B 0.00
Aerie Pharmaceuticals (AERI) United States $2.899B 0.00
Heron Therapeutics (HRTX) United States $2.806B 0.00
USANA Health Sciences (USNA) United States $2.679B 25.77
Portola Pharmaceuticals (PTLA) United States $2.629B 0.00
Endo (ENDP) Ireland $2.495B 3.40
Spectrum Pharmaceuticals (SPPI) United States $2.471B 0.00
Enanta Pharmaceuticals (ENTA) United States $2.357B 43.54
Xencor (XNCR) United States $2.355B 0.00
TESARO (TSRO) United States $2.151B 0.00
Zogenix (ZGNX) United States $2.057B 0.00
PTC Therapeutics (PTCT) United States $1.857B 0.00
Pacira Pharmaceuticals (PCRX) United States $1.517B 0.00
Corcept Therapeutics (CORT) United States $1.498B 25.00
TherapeuticsMD (TXMD) United States $1.433B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.421B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $1.404B 0.00
Impax Laboratories (AMRX) United States $1.368B 29.40
ImmunoGen (IMGN) United States $1.364B 0.00
Radius Health (RDUS) United States $1.269B 0.00
Endocyte (ECYT) United States $1.204B 0.00
Tricida (TCDA) United States $1.186B 0.00
Esperion Therapeutics (ESPR) United States $1.158B 0.00
Flexion Therapeutics (FLXN) United States $1.019B 0.00
Karyopharm Therapeutics (KPTI) United States $0.944B 0.00
OptiNose (OPTN) United States $0.916B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.844B 0.00
Translate Bio (TBIO) United States $0.714B 0.00
GlycoMimetics (GLYC) United States $0.699B 0.00
Dova Pharmaceuticals (DOVA) United States $0.686B 0.00
Collegium Pharmaceutical (COLL) United States $0.666B 0.00
CASI Pharmaceuticals (CASI) United States $0.636B 0.00
Odonate Therapeutics (ODT) United States $0.634B 0.00
Aclaris Therapeutics (ACRS) United States $0.633B 0.00
ChemoCentryx (CCXI) United States $0.606B 42.50
BioCryst Pharmaceuticals (BCRX) United States $0.587B 0.00
Akebia Therapeutics (AKBA) United States $0.585B 0.00
Siga Technologies (SIGA) United States $0.566B 0.00
Depomed (DEPO) United States $0.518B 0.00
ArQule (ARQL) United States $0.514B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.507B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.491B 0.00
Forty Seven (FTSV) United States $0.473B 0.00
Lannett Co Inc (LCI) United States $0.469B 4.32
Synergy Pharmaceuticals (SGYP) United States $0.469B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.460B 0.00
ElectroCore (ECOR) United States $0.436B 0.00
Dermira (DERM) United States $0.426B 0.00
Xeris Pharmaceuticals (XERS) United States $0.411B 0.00
Majesco Entertainment (COOL) United States $0.410B 0.00
Mast Therapeutics (SVRA) United States $0.388B 0.00
Concert Pharmaceuticals (CNCE) United States $0.382B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.336B 26.24
Achaogen (AKAO) United States $0.320B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.318B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.313B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.312B 0.00
Minerva Neurosciences (NERV) United States $0.310B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.306B 0.00
Neon Therapeutics (NTGN) United States $0.305B 0.00
Tyme Technologies (TYME) United States $0.295B 0.00
Zafgen (ZFGN) United States $0.294B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.251B 0.00
Jounce Therapeutics (JNCE) United States $0.246B 0.00
DURECT (DRRX) United States $0.244B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.239B 0.00
Ampio Pharmaceuticals (AMPE) United States $0.227B 0.00
Ocular Therapeutix (OCUL) United States $0.226B 0.00
ProNAi Therapeutics (SRRA) Canada $0.223B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.223B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.221B 0.00
Zomedica Pharmaceuticals (ZOM) United States $0.213B 0.00
Redhill Biopharma (RDHL) Israel $0.212B 0.00
Galectin Therapeutics (GALT) United States $0.211B 0.00
Aratana Therapeutics (PETX) United States $0.210B 0.00
Ardelyx (ARDX) United States $0.209B 0.00
IMV INC (IMV) Canada $0.207B 0.00
Immune Design (IMDZ) United States $0.207B 0.00
Melinta Therapeutics (MLNT) United States $0.187B 0.00
Neos Therapeutics (NEOS) United States $0.178B 0.00
ContraFect (CFRX) United States $0.178B 0.00
Nature's Sunshine Products (NATR) United States $0.172B 0.00
Adherex Technologies (FENC) United States $0.171B 0.00
MediWound (MDWD) Israel $0.169B 0.00
Calithera Biosciences (CALA) United States $0.165B 0.00
Aldeyra Therapeutics (ALDX) United States $0.159B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.157B 0.00
Opexa Therapeutics (ACER) United States $0.152B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.151B 0.00
MEI Pharma (MEIP) United States $0.149B 0.00
Cardiome Pharma (CORV) Canada $0.141B 0.00
CTI BioPharma (CTIC) United States $0.136B 0.00
Molecular Templates (MTEM) United States $0.135B 0.00
Forward Pharma (FWP) Denmark $0.128B 0.00
Juniper Pharmaceuticals (JNP) United States $0.128B 191.67
Adamis Pharmaceuticals (ADMP) United States $0.127B 0.00
SteadyMed (STDY) Israel $0.122B 0.00
Rafael Holdings (RFL) United States $0.120B 0.00
Recro Pharma (REPH) United States $0.117B 0.00
Iterum Therapeutics (ITRM) Ireland $0.117B 0.00
Otonomy (OTIC) United States $0.114B 0.00
Affimed (AFMD) Germany $0.113B 0.00
Nivalis Therapeutics (ALPN) United States $0.113B 0.00
Infinity Pharmaceuticals (INFI) United States $0.107B 0.00
BioLineRx (BLRX) Israel $0.097B 0.00
Champions Oncology (CSBR) United States $0.096B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.094B 0.00
KalVista Pharmaceuticals (KALV) United States $0.093B 0.00
Actinium Pharmaceuticals (ATNM) United States $0.087B 0.00
SCYNEXIS (SCYX) United States $0.086B 0.00
Natural Alternatives (NAII) United States $0.078B 9.96
Novan (NOVN) United States $0.076B 0.00
Trillium Therapeutics (TRIL) Canada $0.075B 0.00
KemPharm (KMPH) United States $0.071B 0.00
Genocea Biosciences (GNCA) United States $0.066B 0.00
Tokai Pharmaceuticals (NVUS) United States $0.061B 0.00
Oasmia Pharmaceutical AB (OASM) Sweden $0.061B 0.00
Capnia (SLNO) United States $0.055B 0.00
Mannatechorporated (MTEX) United States $0.055B 13.40
Heat Biologics (HTBX) United States $0.047B 0.00
Avenue Therapeutics (ATXI) United States $0.043B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.041B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.040B 36.31
Onconova Therapeutics (ONTX) United States $0.036B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.036B 0.00
ProPhase Labs (PRPH) United States $0.035B 3.90
Tonix Pharmaceuticals Holding (TNXP) United States $0.035B 0.00
HANCOCK JAFFE (HJLI) United States $0.035B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.034B 0.00
Biomerica (BMRA) United States $0.034B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.034B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.034B 0.00
Xenetic Biosciences (XBIO) United States $0.032B 0.00
IsoRay (ISR) United States $0.030B 0.00
Lipocine (LPCN) United States $0.030B 0.00
Citius Pharmaceuticals (CTXR) United States $0.029B 0.00
Regulus Therapeutics (RGLS) United States $0.029B 0.00
Shineco (TYHT) China $0.029B 2.45
NanoViricides (NNVC) United States $0.028B 0.00
Can-Fite Biopharma (CANF) Israel $0.025B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.025B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.025B 0.00
Aradigm (ARDM) United States $0.022B 0.00
Cyanotech (CYAN) United States $0.022B 21.21
Aviragen Therapeutics (VXRT) United States $0.022B 0.00
Aralez Pharmaceuticals (ARLZ) Canada $0.021B 0.00
Midatech Pharma (MTP) United Kingdom $0.020B 0.00
ESSA Pharma (EPIX) Canada $0.020B 0.00
Egalet (EGLT) United States $0.019B 0.00
CollPlant Holdings Sponsored ADR (CLGN) Israel $0.018B 0.00
Bio-Path Holdings (BPTH) United States $0.017B 0.00
Intellipharmaceutics (IPCI) Canada $0.016B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.015B 0.00
Pain Therapeutics (PTIE) United States $0.015B 0.00
DelMar Pharmaceuticals (DMPI) Canada $0.014B 0.00
Skyline Medical (AIPT) United States $0.014B 0.00
India Globalization Capital (IGC) United States $0.014B 0.00
Ohr Pharmaceuticals (OHRP) United States $0.011B 0.00
Ritter Pharmaceuticals (RTTR) United States $0.011B 0.00
PharmAthene (ALT) United States $0.010B 0.00
Jaguar Animal Health (JAGX) United States $0.010B 0.00
Apricus Biosciences (APRI) United States $0.009B 0.00
OncoGenex Pharmaceuticals (ACHV) United States $0.009B 0.00
RXi Pharmaceuticals (RXII) United States $0.008B 0.00
Biostar Pharmaceuticals (BSPM) China $0.006B 3.20
Bio Blast Pharma (ORPN) Israel $0.005B 0.00
Auris Medical Holding AG (EARS) Switzerland $0.002B 0.00
Advanced Accelerator Applications (AAAP) France $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00